Yeah i don't understand how BP wouldn't see the value here especially considering the recent $4.6b buyout of a company with a mere fraction of what TLX has and future potential.
TLX591 need only show a marginal improvement in OS to smash pluvicto, considering all of the other benefits it has over the latter.
3x OS again and we take it all.
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS, page-157
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
1.840(10.5%) |
Mkt cap ! $6.488B | |||
| Open | High | Low | Value | Volume |
| $19.85 | $20.16 | $19.18 | $88.79M | 4.509M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10943 | $19.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.39 | 1125 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |